Organon CEO Uncertain Over Long-Term Future Of Biosimilars Business
Kevin Ali: ‘I Don't Know Where The Biosimilar Business Will Be In The Next Decade’
Organon CEO Kevin Ali has acknowledged that the long-term future for the biosimilars business is unclear, despite the firm’s biosimilars segment currently acting as a solid growth driver for the company.
